Upgrade to SI Premium - Free Trial

Quest Diagnostics (DGX) Tops Q2 EPS by 5c, Revenues Beat; Offers FY19 EPS/Revenue Guidance

July 23, 2019 6:47 AM
Quest Diagnostics (NYSE: DGX) reported Q2 EPS of $1.73, $0.05 better than the analyst estimate of $1.68. Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Earnings Guidance Management Comments

Next Articles